Proactive Complex Hormone Therapy in the Clinical Guideline for the Managing the Potential Donor Organs in BrainDead Donors

Goal of study: to improve hemodynamics, respiratory exchange and metabolism of potential donor organs by using combination of Lthyroxin, triiodothyronine, methylprednisolone, desmopressin acetate and insulin.

Material and Methods: The clinical study included 98 potential donors (PD) with confirmed diagnosis of brain death. Braindead PD were divided into two groups: the 1st group included 43 PD with traumatic brain injury; the 2nd group included 55 PD with a stroke. PD from the 1st and 2nd groups were divided into two subgroups: main subgroup (n=18 and n=30) included those who received Lthyroxine, triiodothyronine and dessom pressin orally; control subgroup (n=25 and n=25) included those who did not receive these drugs. Hemodynamics, electrolytes, biochemical parameters, respiratory exchange and free triiodothyronine and thyroxine in blood were determined during the study.

Results and discussion: In the course of the intensive therapy in control subgroups of both groups of PD the doses of noradrenalin and dopamine were not changed. However, the doses of noradrenalin and dopamine were decreased significantly in main subgroups of both groups during the course of the hormone therapy. There were no significant changes in hemodynamics in PD from both control subgroups, whereas in main groups hemodynamics parameters were decreased due to hormone therapy. Significant changes of blood pressure were observed in the main subgroups. Despite exogenous administration, in the main subgroups T3 remained at the lower limit of norm, whereas T4 increased. Improved hemodynamics and gas exchange were revealed in PD following hormone therapy that was important for the blood flow in organs. Following transplantation, in recipients of organs from control subgroup of PD the rejections of the transplants were significantly more frequent than rejections of organs from PD which comprized the main subgroup receiving hormones.

Conclusion. Hormone administration to braindead PD with confirmed brain death led to significantly reduced doses of noradrenalin and dopamine and improved hemodynamics and gas exchange parameters. Oral administration of thyroid and hypophisis hormones to PD with confirmed brain death seems feasible.

1. Khubutiya M.S., Ryk A.A., Kiselev V.V., Aleksandrova I.V., Grishin A.V., Godkov M.A., Klychnikova E.V., Shavrina N.V., Sogreshilin S.S., Titova G.P., Borovkova N.V. Enteralnoe pitanie v sostave kompleksnogo lecheniya patsienta posle transplantatsii tonkoi kishki. Obshchaya Reanimatologiya. [Enteral feeding as a part of combination treatment in a patient after small intestine transplantation. General Reanimatology]. 2014; 10 (1):43—57. (In Russ.) DOI:10.15360/18139779201414357. [In Russ.]

2. Kondratyeva E.A., Yaroshetsky A.I. Smert mozga. V kn.: Gelfand B.R., Saltanov A.I. (red.). Intensivnaya terapiya. Natsionalnoe rukovodstvo. t.1. [Brain death. In: Gelfand B.R., Saltanov A.I. (eds.). Intensive therapy. National guidelines. v.1]. Moscow: GEOTARMedia; 2009: 403—405. [In Russ.]

3. Mashkovsky M.D. Lekarstvennye sredstva. 16e izd. [Drugs.16th ed.]. Moscow: Novaya Volna; 2012: 1216. [In Russ.]

4. Dedov I.I., Melnichenko G.A. (red.). Endokrinologiya. Natsionalnoe rukovodstvo. [Endocrinology. National guidelines]. Moscow: GEO TARMedia; 2013: 752. [In Russ.]

5. Mori K., Shingu K., Nakao S. Smert mozga. V kn.: Miller R. Anesteziya Ronalda Millera. t.4. [Brain death. In: Miller R. Miller`s anesthesia. v.4]. SanktPeterburg: Chelovek; 2015: 3237—3258. [In Russ.]

6. Cooper D.K., Wicomb W.N., Novitzky D. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system: the initial clinical experience. Clin. Transpl. 2006: 552—554. PMID: 18365429

7. Gramm H.J., Meinhold H., Bickel U., Zimmermann J., von Hammerstein B., Keller F., Dennhardt R., Voigt K. Acute endocrine failure after brain death? Transplantation. 1992; 54 (5): 851—857. http://dx.doi.org/10.1097/0000789019921100000016. PMID: 1332223

8. Howlett T.A., Keogh A.M., Perry L., Touzel R., Rees L.H. Anterior and poste rior pituitary function in brainstemdead donors. A possible role for hormonal replacement therapy. Transplantation. 1989; 47 (5): 828—834. http://dx.doi.org/10.1097/0000789019890500000016. PMID: 2718243

9. Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid. 1997; 7 (1): 139—145. http://dx.doi.org/10.1089/thy.1997.7.139. PMID: 9086582

10. Jeevanandam V., Todd B., Regillo T., Hellman S., Eldridge C., McClurken J. Reversalof donor myocardial dysfunction by triiodothyronine replacement therapy. J. Heart Lung. Transplant. 1994; 13 (4): 681—687. PMID: 7947885

11. McCann S.M., AntunesRodrigues J., Franci C.R., AnselmoFranci J.A., Karanth S., Rettori V. Role of the hypothalamic pituitary adrenal axisin the control of the response to stress and infection. Braz. J. Med. Biol. Res. 2000; 33 (10): 1121—1131. http://dx.doi.org/10.1590/S0100879X2000001000001. PMID: 11004712

12. Novitzky D. Selection and management of cardiac allograft donors. Curr. Opin. Cardiol. 1996; 11 (2): 174—182. http://dx.doi.org/10.1097/0000157319960300000011. PMID: 8736689

13. Novitzky D., Mi Z., Sun Q., Collins J.F., Cooper D.K. Thyroid hormone therapy in themanagement of 63,593 braindead organ donors: a retrospective analysis. Transplantation. 2014; 98 (10): 1119—1127. http://dx.doi.org/10.1097/TP.0000000000000187. PMID: 25405914

14. Novitzky D., Wicomb W.N., Cooper D.K., Rose A.G., Fraser R.C., Barnard C.N. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the Chacma baboon. J. Heart Transplant. 1984; 4: 63—69.

15. Powner D.J., Hendrich A., Lagler R.G., Ng R.H., Madden R.L. Hormonal changes in brain dead patients. Crit. Care Med. 1990; 18 (7): 702—708. PMID: 2194745

16. Salim A., Vassiliu P., Velmahos G.C., Sava J., Murray J.A., Belzberg H., Asensio J.A., Demetriades D. The role of thyroid hormone administration in potential organ donors. Arch. Surg. 2001; 136 (12): 1377—1380. http://dx.doi.org/10.1001/archsurg.136.12.1377. PMID: 11735863

17. Prikaz Ministerstva zdravookhranenia Rossiiskoi Federatsii ot 20 dekabrya 2001 goda № 460 «Ob utverzhdenii Instruktsii po konstatatsii smerti cheloveka na osnovanii diagnoza smerti mozga» (zaregistrirovan Ministerstvom yustitsii Rossiiskoi Federatsii 17 yanvarya 2002 goda, registratsionnyi № 3170). [Order of the Ministry of Health of the Russian Federation of December 20, 2001 № 460 «On approval of the Instructions for ascertaining death of a person on the basis of the diagnosis of brain death» (registered by the RF Ministry of Justice of 17 January 2002, registration № 3170)]. Zdravookhranenie. 2002; 3. [In Russ.]

18. Wheeldon D.R., Potter C.D., Oduro A., Wallwork J., Large S.R. Transforming the «unacceptable» donor: outcomes from the adoption of a standardized donor management technique. J. Heart Lung Transplant. 1995; 14 (4): 734—742. PMID: 7578183

19. Zuppa A.F., Nadkarni V., Davis L., Adamson P.C., Helfaer M.A., Elliott M.R., Abrams J., Durbin D. The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit. Care Med. 2004; 32 (11): 2318—2322. PMID: 15640648

20. Niradjan N., Daggi M. Smert mozga. V kn.: Osnovy intensivnoi terapii. Rukovodstvo Vsemirnoi Federatsii Obshchestv anesteziologov (VFSA). Russkaya versiya zhurnala Update in Anaesthesia. [Brain death. In: Basics of intensive therapy. Manual of the World Federation of anesthesiologists (WFSA). Russian version of the Update in Anaesthesia]. 2014: 419—423. [In Russ.]